17-39605523-CAAG-C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PM4_Supporting
The NM_006160.4(NEUROD2):c.1074_1076delCTT(p.Leu359del) variant causes a disruptive inframe deletion change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006160.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEUROD2 | ENST00000302584.5 | c.1074_1076delCTT | p.Leu359del | disruptive_inframe_deletion | Exon 2 of 2 | 1 | NM_006160.4 | ENSP00000306754.4 | ||
NEUROD2 | ENST00000580874.1 | n.4252_4254delCTT | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1074_1076delCTT (p.L359del) alteration is located in exon 2 (coding exon 1) of the NEUROD2 gene. This alteration consists of an in-frame deletion of 3 nucleotides between nucleotide positions c.1074 and c.1076, resulting in the deletion of <NA> residues. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.